Understanding the Shift in Biotech Pricing Strategies

Recent market research reveals a significant trend in biotech pricing strategies, particularly as competition intensifies. With companies leveraging value-based pricing models, it’s crucial for us in sales to grasp these dynamics to effectively communicate value to our clients. Have any of you taken courses or found resources that cover these recent shifts in-depth?

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌‍⁠‌‌‍‌‌‌‍‌​‌‍‍‌‌‍​⁠‌‍​‌‌‍⁠​‌⁠​⁠‌‍​‌‌‍⁠​‌‍‌‌‌⁠​⁠​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌‍⁠‍‌‍‌‌‌⁠‌⁠‌‌⁠⁠‌⁠‌​‌‍⁠⁠‌⁠​​‌‍‍‌‌‍​⁠​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​‍​‍‌‍⁠‍‌‍‌‌‌⁠‌⁠​‍​‍​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‍​⁠​‌​⁠​‌​⁠​‍​⁠​​​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍​⁠‌‌‌‍⁠‌​‍⁠‌​‍⁠‌​⁠‍​‌‌​⁠‌​​‌‌‍⁠⁠‌​⁠‌‌‌​‍‌‌‍‍‌⁠‌‍‌‌‍‌‌​​‌‌​⁠‌‌⁠‍‍​‍​‍‌⁠⁠‌​​